Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report
DOI:
https://doi.org/10.61788/njn.v1i27.09Keywords:
multiple sclerosis, Guillian-Barre syndrome, demyelinating diseasesAbstract
Multiple Sclerosis (MS) and Guillain-Barré Syndrome (GBS) are demyelinating diseases affecting the central nervous system and peripheral nervous system, respectively. Both disorders share common immunopathogenic mechanisms, genetic predispositions, and environmental risk factors. The co-occurrence of MS and GBS, although rare, has been reported in the literature, suggesting a possible link between these conditions. Here, we present a case of a 48-year-old female who initially developed MS, followed by GBS, and provide a review of relevant literature.
References
Murta V, Ferrari C. Peripheral Inflammation and Demyelinating Diseases. In: Bernhardi R von, editor. Advances in Experimental Medicine and Biology. 1st ed. Springer International Publishing; 2016. p. 263-85.
Mehndiratta MM, Gulati NS. Central and peripheral demyelination // J Neurosci Rural Pract. 2014 Jan;5(1):84-6. doi: 10.4103/0976-3147.127887
Vedeler CA, Matre R, Sadallah S, Schifferli J. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis // J Neuroimmunol. 1996;67(1):17-20.
Hassan A, El-Mazny A, Saher M, Ismail II, Almuqbil M. Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report // Dubai Med J 19 April 2021; 4 (1): 31-35. doi: 10.1159/000512773
Vedeler CA, Myhr KM, Nyland H. Fc receptors for immunoglobulin G: a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis // J Neuroimmunol. 2001;118(2):187-93
Guan Y, Jakimovski D, Ramanathan M, Weinstock-Guttman B, et al. The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging // Neural Regen Res. 2019 Mar;14(3):373-386. doi: 10.4103/1673-5374.245462
Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study // Mult Scler. 2010;16(7):855-61.
Etemadifar M, Roomizadeh P, Abtahi SH, Sajjadi S, A, et al. Linkage of multiple sclerosis and Guillain-Barre syndrome: a population-based survey in Isfahan, Iran // Autoimmune Dis. 2012; 2012:232139
Pandit L. Multiple sclerosis: Treatment options. January 2013. doi: 10.13140/2.1.2577.9845.
Toosy A, Ciccarelli O, Thompson A. Chapter 24 - Symptomatic treatment and management of multiple sclerosis. Handbook of Clinical Neurology. Volume 122, 2014, Pages 513-562.
Sriwastava S, Elkhooly M, Amatya S, Shrestha K, et al. Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis // J Neuroimmunol. 2024 May 15;390:578315. doi: 10.1016/j.jneuroim.2024.578315
Hughes RA, Raphaël JC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002063. doi: 10.1002/14651858.CD002063
Hughes RA, Swan AV, Raphael JC, Annane D, Van Koningsveld R, Van Doorn PA. Immunotherapy for Guillain-Barre syndrome: a systematic review // Brain. 2007;130:2245-2557. doi: 10.1093/brain/awm004
Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome.Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001798. doi: 10.1002/14651858.CD001798
Verboon C, Van Doorn PA, Jacobs BC. Treatment dilemmas in Guillain-Barre syndrome // J Neurol Neurosurg Psychiatry. 2017; 88:346-352. doi:10.1136/jnnp-2016-314862
Medina R, Derias AM, Lakdawala M, Speakman S, Lucke-Wold B. Overview of emerging therapies for demyelinating diseases // World J Clin Cases 2024; 12(30): 6361-6373. doi: 10.12998/wjcc.v12.i30.6361
Harlow DE, Honce JM, Miravalle AA. Remyelination Therapy in Multiple Sclerosis // Front Neurol. 2015;6:257. doi: 10.3389/fneur.2015.00257
Punjani N, Senthilnathan V, Ahuja CS, Fehlings MG. Chapter 25 - Clinical trials: cellular regenerative approaches. In: Neural Repair and Regeneration After Spinal Cord Injury and Spine Trauma. Academic Press, 2022: 441-471. doi: 10.1016/B978-0-12-819835-3.00006-X
Graves JS, Krysko KM, Hua LH, Absinta M, et al. Ageing and multiple sclerosis // Lancet Neurol. 2023 Jan;22(1):66-77. doi: 10.1016/S1474-4422(22)00184-3
Cunniffe N, Coles A. Promoting remyelination in multiple sclerosis // J Neurol. 2021 Jan;268(1):30-44. doi: 10.1007/s00415-019-09421-x
Wang JY, Yuan Y, Zhang SY, Lu SY, et al. Remodeling of the Intra-Conduit Inflammatory Microenvironment to Improve Peripheral Nerve Regeneration with a Neuromechanical Matching Protein-Based Conduit // Adv Sci (Weinh). 2024;11:e2302988. doi: 10.1002/advs.202302988
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
